Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols
- Ozgur Can Eren
- , Pelin Bagci
- , Serdar Balci
- , Nobuyuki Ohike
- , Burcu Saka
- , Cenk Sokmensuer
- , Can Berk Leblebici
- , Yue Xue
- , Michelle D. Reid
- , Alyssa M. Krasinskas
- , David Kooby
- , Shishir K. Maithel
- , Juan Sarmiento
- , Jeanette D. Cheng
- , Orhun Cig Taskin
- , Yersu Kapran
- , Zeynep Cagla Tarcan
- , Claudio Luchini
- , Aldo Scarpa
- , Olca Basturk
- , N. Volkan Adsay
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.